News

Kamada Announces Appointment of Michal Stein, M.D., as Vice President and Medical Director

REHOVOT, Israel, June 05, 2017 (GLOBE NEWSWIRE) — Kamada Ltd. (KMDA) (KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced today the appointment of Michal Stein, M.D., as Vice President and Medical Director for Immunology.  Dr. Stein will lead Kamada’s medical affairs in all of the Company’s Immunology and specific IgGs products and indications, such as Type-1 Diabetes, Graft vs. Host Disease (GvHD), transplantations and Anti-Rabies IgG, as well as potential new initiatives.

2017-06-27T12:21:56+00:00